Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2014
05/06/2014US8715922 Virus causing respiratory tract illness in susceptible mammals
05/06/2014US8715751 Artemisinins in the clinical and veterinary management of kinetoplastid infections
05/06/2014US8715688 Method for identification, isolation and production of antigens to a specific pathogen
05/06/2014US8715683 RANK ligand polypeptides
05/06/2014US8715675 Vascular targets for detecting, imaging and treating neoplasia or neovasculature
05/06/2014US8715672 Treatment of diseases linked to pathological kinin formation
05/06/2014US8715670 Human monoclonal antibody that specifically binds to VCAM-1 and a composition for treating an inflammatory disease or a cancer comprising the same
05/06/2014US8715668 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 and uses thereof
05/06/2014US8715666 Method for the potentiation of opioid analgesics effects on pain
05/06/2014US8715664 Use of human TNFα antibodies for treatment of erosive polyarthritis
05/06/2014US8715663 Epitopes
05/06/2014US8715659 Single domain brain-targeting antibody fragments derived from llama antibodies
05/06/2014US8715658 Methods for treating conditions mediated by the inflammatory cytokine cascade using GAPDH inhibitors
05/06/2014US8715657 Therapeutic antibodies binding IL12Rβ1
05/06/2014US8715655 Human anti-α9 integrin antibody
05/06/2014CA2711798C Composition comprising antibody that binds to domain ii of her2 and acidic variants thereof
05/06/2014CA2687583C Chimeric and humanized anti-cd44 antibodies that mediate cancer cell cytotoxicity
05/06/2014CA2682212C Anti-sclerostin antibodies
05/06/2014CA2631292C Derivatised wt1 cancer antigen peptides and their use
05/06/2014CA2612937C Concentrated protein lyophilates, methods, and uses
05/06/2014CA2555210C Chemically programmable immunity
05/06/2014CA2518262C Uses of il-23 agonists and antagonists; related reagents
05/06/2014CA2511838C Uses of mammalian cytokine; related reagents
05/06/2014CA2362963C Human suppressor of fused
05/06/2014CA2287911C Apo-2 receptor
05/01/2014WO2014066889A1 Synthetic env proteins
05/01/2014WO2014066590A1 Jam-c antibodies and methods for treatment of cancer
05/01/2014WO2014066532A1 Combination of anti-kir and anti-ctla-4 antibodies to treat cancer
05/01/2014WO2014066530A2 ANTIGEN BINDING PROTEINS THAT BIND ErbB3
05/01/2014WO2014066167A1 Antibodies to interleukin-6 and uses thereof
05/01/2014WO2014066058A1 Dual variable domain (dvd) immunoglobulins for reducing major adverse cardiovascular events (mace) in diabetic patients subsequent to stent placement
05/01/2014WO2014065961A1 M971 chimeric antigen receptors
05/01/2014WO2014065945A1 Antibodies with engineered igg fc domains
05/01/2014WO2014065822A1 Hepatitis c virus neutralizing epitopes, antibodies, and methods
05/01/2014WO2014065403A1 Anti-human cd40 monoclonal antibody, and use thereof
05/01/2014WO2014065402A1 Anti-human cd40 monoclonal antibody, and use thereof
05/01/2014WO2014065375A1 Method for inhibiting proliferation of cell by oxidative stress
05/01/2014WO2014065323A1 Test method and test kit for psychiatric ailments
05/01/2014WO2014065210A1 Vaccine for preventing porcine edema disease
05/01/2014WO2014064682A1 Combinations of epidermal growth factor receptor targeting antibodies for treating cancer
05/01/2014WO2014064292A1 A method for preventing or treating atrial fibrillation
05/01/2014WO2014064287A1 Bi-specific affinity reagents for cell-lineage-specific tnf-alpha neutralisation
05/01/2014WO2014064092A1 Polypeptides capable of cellular internalization
05/01/2014WO2014064080A1 Polypeptides specifically binding to il-23
05/01/2014WO2014063703A1 Monoclonal antibodies
05/01/2014WO2014063368A1 Humanized monoclonal antibody in extracellular domain of anti-human death receptor 5
05/01/2014WO2014063253A1 Anti-campylobacter jejuni antibodies and uses therefor
05/01/2014WO2014063206A1 Methods for classifying tumors and uses therefor
05/01/2014WO2014037785A3 Catalytic antibodies and uses thereof
05/01/2014WO2014037588A3 Methods and compounds for preventing, treating and diagnosing an inflammatory condition
05/01/2014WO2014033304A3 Highly diverse combinatorial antibody libraries
05/01/2014WO2014031648A3 Antibodies to risperidone and use thereof
05/01/2014WO2014031646A3 Molecules with antigen binding and polyvalent fc gamma receptor binding activity
05/01/2014WO2014031640A3 Antibodies to aripiprazole and use thereof
05/01/2014WO2013179143A3 Sensitization of cancer cells by the removal of soluble tumor necrosis factor receptors
05/01/2014WO2013088378A3 Method of detecting the presence of an antibody in a sample
05/01/2014US20140121358 Humanized antibody and process for preparing same
05/01/2014US20140121357 Method for producing injectable formulations of blood-derived protein materials, and materials obtained using said method
05/01/2014US20140120614 Antibodies against clostridium difficile toxins and uses thereof
05/01/2014US20140120613 Bivalent, bispecific antibodies
05/01/2014US20140120583 Cell culture process
05/01/2014US20140120581 Heterodimer protein composition
05/01/2014US20140120580 System for antibody expression and assembly
05/01/2014US20140120561 Antibody specifically binding to insulin-like growth factor-1
05/01/2014US20140120560 Generation of new pancreatic beta cells
05/01/2014US20140120555 Anti-cxcr4 antibody with effector functions and its use for the treatment of cancer
05/01/2014US20140120553 T2r, a novel family of taste receptors
05/01/2014US20140120117 Treatment of tumors using specific anti-l1 antibody
05/01/2014US20140120115 Antibodies that are cross-reactive for macrophage migration inhibitory factor (mif) and d-dopachrome tautomerase (d-dt)
05/01/2014US20140120114 Antibodies to EphA3
05/01/2014US20140120113 Human binding molecules capable of neutralizing influenza a viruses of phylogenetic group 1 and phylogenetic group 2 and influenza b viruses
05/01/2014US20140120110 ANGIOGENIC AND IMMUNOLOGIC APPLICATIONS OF ANTI-CD160 SPECIFIC COMPOUNDS OBTAINABLE FROM mAb CL1-R2
05/01/2014US20140120109 Human Antibodies to Human TNF-Like Ligand 1A (TL1A)
05/01/2014US20140120107 Genes of an otitis media isolate of nontypeable haemophilus influenzae
05/01/2014US20140120106 Stimulation of Arterial Collateral Growth and Lymphogenesis
05/01/2014US20140120105 Therapeutic targeting of ficolin-3
05/01/2014US20140120104 Cadherin-11 ec1 domain antagonists for treating inflammatory joint disorders
05/01/2014US20140120103 Anti-cd40 antibodies and methods of use
05/01/2014US20140120102 Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2)
05/01/2014US20140120101 Anti-IL12Rbeta1 Antibodies And Their Use In Treating Autoimmune And Inflammatory Disorders
05/01/2014US20140120100 Compositions and methods for preventing erythropoietin-associated hypertension
05/01/2014US20140120098 Fibcd1 for the prevention and treatment of diseases
05/01/2014US20140120096 Bispecific igg antibodies as t cell engagers
05/01/2014US20140120095 Bispecific binding molecules for anti-angiogenesis therapy
05/01/2014US20140120094 Use of IL-20 Antagonists for Treating Liver Diseases
05/01/2014US20140120093 Anti-Infective Binding Proteins that Bind AIP2
05/01/2014US20140120092 Antigen Binding Proteins that Bind ErbB3
05/01/2014US20140120091 Fusion proteins for therapy of autoimmune and cardiovascular disease
05/01/2014US20140120090 Cross-linking polypeptide that induces apoptosis
05/01/2014US20140120089 Antibodies to insulin-like growth factor i receptor
05/01/2014US20140120085 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy
05/01/2014US20140120084 Methods of administering beta7 integrin antagonists
05/01/2014US20140120035 RS7 Antibodies
04/2014
04/30/2014EP2725037A1 Monoclonal antibodies binding canine CD20
04/30/2014EP2725036A1 Recombinant anti-epidermal growth factor receptor antibody compositions
04/30/2014EP2725035A1 Antibody therapy for use in the digestive tract
04/30/2014EP2725034A1 Carrier immunoglobulins and uses thereof
04/30/2014EP2725033A1 Method for producing protein preparation
04/30/2014EP2724728A1 Complexes of IL-15 and IL-15R alpha and uses thereof
04/30/2014EP2723880A2 Hybrid polymerases having the ability to produce long amplicons
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 1494